Viyash Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Viyash Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs449.00 Million ≈ $4.86 Million USD) by net assets (Rs8.87 Billion ≈ $95.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Viyash Scientific Limited for the company's overall valuation and market capitalisation.
Viyash Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Viyash Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SEQUENT stock price and chart for real-time trading data and today's change.
Viyash Scientific Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Viyash Scientific Limited ranked by their cash flow conversion efficiency. Review how much free cash does Viyash Scientific Limited generate to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gokaldas Exports Limited
NSE:GOKEX
|
0.050x |
|
Hypoport SE
XETRA:HYQ
|
0.012x |
|
Shenzhen Sosen Electronics Co.Ltd.
SHE:301002
|
-0.007x |
|
Sinon Corp
TW:1712
|
0.058x |
|
Kambi Group PLC Series B
LSE:0EAW
|
0.089x |
|
Nanfang Ventilator Co Ltd
SHE:300004
|
0.015x |
|
Pagerduty Inc
NYSE:PD
|
0.094x |
|
Yaari Digital Integrated Services Limited
NSE:YAARI
|
0.000x |
Annual Cash Flow Conversion Efficiency for Viyash Scientific Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Viyash Scientific Limited from 2006 to 2025. Also see balance sheet size of Viyash Scientific Limited for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs7.70 Billion ≈ $83.31 Million |
Rs833.60 Million ≈ $9.02 Million |
0.108x | +152.16% |
| 2024-03-31 | Rs7.13 Billion ≈ $77.10 Million |
Rs305.95 Million ≈ $3.31 Million |
0.043x | +91.28% |
| 2023-03-31 | Rs7.49 Billion ≈ $81.02 Million |
Rs168.08 Million ≈ $1.82 Million |
0.022x | -45.73% |
| 2022-03-31 | Rs7.40 Billion ≈ $80.04 Million |
Rs305.95 Million ≈ $3.31 Million |
0.041x | -72.03% |
| 2021-03-31 | Rs7.76 Billion ≈ $83.96 Million |
Rs1.15 Billion ≈ $12.41 Million |
0.148x | -6.20% |
| 2020-03-31 | Rs7.32 Billion ≈ $79.15 Million |
Rs1.15 Billion ≈ $12.47 Million |
0.158x | +1.45% |
| 2019-03-31 | Rs7.47 Billion ≈ $80.78 Million |
Rs1.16 Billion ≈ $12.55 Million |
0.155x | +135.05% |
| 2018-03-31 | Rs6.85 Billion ≈ $74.03 Million |
Rs452.39 Million ≈ $4.89 Million |
0.066x | +1013.61% |
| 2017-03-31 | Rs9.94 Billion ≈ $107.50 Million |
Rs-71.90 Million ≈ $-777.57K |
-0.007x | -12597.48% |
| 2016-03-31 | Rs9.48 Billion ≈ $102.51 Million |
Rs-540.00K ≈ $-5.84K |
0.000x | +99.94% |
| 2015-03-31 | Rs2.38 Billion ≈ $25.76 Million |
Rs-235.49 Million ≈ $-2.55 Million |
-0.099x | +86.47% |
| 2014-03-31 | Rs613.06 Million ≈ $6.63 Million |
Rs-447.85 Million ≈ $-4.84 Million |
-0.731x | -1803.87% |
| 2013-03-31 | Rs995.83 Million ≈ $10.77 Million |
Rs-38.21 Million ≈ $-413.23K |
-0.038x | -116.25% |
| 2012-03-31 | Rs1.28 Billion ≈ $13.84 Million |
Rs302.36 Million ≈ $3.27 Million |
0.236x | -37.08% |
| 2011-03-31 | Rs1.35 Billion ≈ $14.60 Million |
Rs506.60 Million ≈ $5.48 Million |
0.375x | +148.36% |
| 2010-03-31 | Rs1.12 Billion ≈ $12.09 Million |
Rs168.95 Million ≈ $1.83 Million |
0.151x | +223.00% |
| 2009-03-31 | Rs405.20 Million ≈ $4.38 Million |
Rs-49.79 Million ≈ $-538.46K |
-0.123x | -14561.60% |
| 2008-03-31 | Rs573.71 Million ≈ $6.20 Million |
Rs487.47K ≈ $5.27K |
0.001x | -99.26% |
| 2007-03-31 | Rs349.24 Million ≈ $3.78 Million |
Rs40.21 Million ≈ $434.91K |
0.115x | -68.51% |
| 2006-03-31 | Rs198.08 Million ≈ $2.14 Million |
Rs72.43 Million ≈ $783.26K |
0.366x | -- |
About Viyash Scientific Limited
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more